AR and neoplasm: Additional studies have shown that PARP-1 may additionally have a role in supporting androgen receptor (AR) activity, and that inhibition of PARP-1 activity in vivo may suppress AR function, decrease tumor growth, and delay the onset of castration resistance (42).